Quarterly report · Q2
2112.TEDINET S100S41D
Period2023-04-01 → 2023-09-30
Filed2023-11-02
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥15.6bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥27.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥13.4bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥546m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥274m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.2bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥731m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥244m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.2bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥244m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥901m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥498m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥138m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥901m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥138m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥26.2bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥25.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥25.2bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥13.7bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥14.8bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥12.5bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥11.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥10.4bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.2bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.4bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.5bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥434m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥447m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥104m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥76m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥374m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥172m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥33.01 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.48 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.28 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.1 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.14 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 47.7% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.2% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2023-04-01 → 2023-09-30 | ¥67m |
| Otherother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥59m |
| Otherother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥8m |
| Otherother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥37m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥59m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥59m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥621m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥964m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥927m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥37m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥211m |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥14.6bn |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥14.6bn |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥13m |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥919m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥15.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥15.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥59m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥1.2bn |
| Otherother segments | revenue | 2022-04-01 → 2022-09-30 | ¥67m |
| Otherother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥59m |
| Otherother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥8m |
| Otherother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥30m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥55m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥55m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥577m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥925m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥891m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥34m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥238m |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥12.4bn |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥12.4bn |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥13m |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥582m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥13.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥13.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥55m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥851m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 498
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 35000000 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 4060000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.1483 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 1527000 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.0558 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 1353000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0494 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 603000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0220 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 550000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0201 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 500000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0183 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 382000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0140 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 340000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0124 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 300000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0110 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 235000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0086 | |
| Number of shares held | CurrentQuarterInstant | 9853000 | |
| Shareholding ratio | CurrentQuarterInstant | 0.3598 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 7620600 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 27368900 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 273689 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 10500 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 35000000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 273689 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 7620600 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 7620600 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.2177 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 7620600 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 7620600 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.2177 | |
| Cash and deposits | Prior1YearInstant | 2212000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 1413000000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 2012000000 | JPY |
| Notes and accounts receivable trade | CurrentQuarterInstant | 2255000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 1395000000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 1571000000 | JPY |
| Work in process | Prior1YearInstant | 206000000 | JPY |
| Work in process | CurrentQuarterInstant | 239000000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 1670000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |